Página 2 - Melhores Basalioma em Portugal é geralmente referido como Carcinoma Basocelular médicos - TOP-50 médicos

O Dr. Yildiz publicou mais de 15 artigos revisados por pares sobre um amplo espectro de cancros em revistas internacionais de prestígio.

• Mais de 10 anos de experiência em oncologia médica.
• Coautor do estudo MODEST sobre a gestão da diabetes em doentes submetidos a tratamentos oncológicos.
• Especialização inclui tumores neuroendócrinos e síndromes paraneoplásicas.
• Publicações sobre casos complexos como timoma e neuroblastoma.
• Trabalho no Hospital Universitário Medipol Mega, em Istambul.

O Dr. Ozatli é especialista em cancros da mama, do pulmão e gastrointestinais, com vasta experiência oncológica em vários hospitais turcos.

• Professor Associado desde 2016
• Trabalhar na Clínica de Oncologia de Ancara e no Hospital Regional de Formação e Investigação de Erzurum
• Estudar medicina na Universidade de Selcuk

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

O Prof. Paksoy é especialista em oncologia médica, com foco em basalioma, atuando no Hospital Medipol Bahçelievler.

• Realizar subespecialização em oncologia médica no Instituto de Oncologia da Universidade de Istambul
• Ser certificado pela ESMO em Oncologia Médica desde 2022
• Participar ativamente em múltiplos ensaios clínicos internacionais para vários tipos de câncer
• Publicar inúmeros artigos de pesquisa em oncologia, incluindo trabalhos sobre cancros de pele

Especializada em viroterapia – um dos mais recentes campos da imunologia – a Dra. Jaunalksne traz abordagens inovadoras ao tratamento.

• Mais de 30 anos de experiência em imunologia
• Chefe do Centro de Imunologia Clínica do Hospital Universitário Clínico Pauls Stradins
• Graduada pelo Instituto Médico de Riga com internato em Medicina Interna

O Dr. Alemdar é especialista em oncologia médica, com ampla formação na Universidade de Akdeniz, uma instituição líder na Turquia.

• Certificado em oncologia médica desde 2018
• Mais de 15 anos de experiência em medicina interna e oncologia
• Ter trabalhado em vários hospitais de prestígio, incluindo o Hospital Universitário de Akdeniz

Especializado no tratamento do cancro da pele com formação especializada no St John’s Institute of Dermatology em Londres – um líder global em oncologia cutânea.

• Membro sénior de cancro da pele nos hospitais Guy’s e St Thomas’
• Palestrante sobre cancro da pele não-melanoma no King’s College London
• Membro da Academia Europeia de Dermatologia e Venereologia
• Formado em técnicas de cirurgia dermatológica em Tel-Aviv e Londres

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

O Dr. Bergman é um dermatologista especializado em oncodermatologia, com foco no diagnóstico e tratamento de cancros de pele, como o basalioma.

• Trabalhar no Rambam Medical Center, um importante hospital israelita
• Dupla competência como dermatologista e oncodermatologista
• Especializar-se em cancro da pele, o que o torna altamente relevante para casos de basalioma

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Especializado em oncologia radioterápica na Universidade de Marmara – foco em tratamentos oncológicos de precisão.

• Certificado em oncologia radioterápica com anos de formação especializada
• Graduado no programa de medicina em inglês da Universidade de Marmara
• Trabalhar no centro de tratamento de câncer do Hospital Emsey

Especialista em procedimentos dermatológicos avançados com experiência em tratamentos a laser e técnicas minimamente invasivas no Holistic Bio Spa®.

• Assistente médico em clínica dermatológica com 5 anos de experiência prática
• Proficiente em máquinas de laser fracionado e rejuvenescimento facial com IPL
• Certificado em biomagnetismo pelo Higher Institute of Biomagnetism
• Experiência extensiva com fototerapia de luz UV para condições de pele
• Habilidoso em auxiliar procedimentos de Botox e preenchimentos